H04.143
Primary lacrimal gland atrophy, bilateral lacrimal glands
Clinical Classification Guidelines
Medical Intelligence & Overview
Bilateral lacrimal gland atrophy is a condition where the tear-producing glands located in both eyes gradually shrink or lose function. This can lead to dry eyes and related discomfort. The condition is classified under ICD-10 as H04.143 and primarily affects the lacrimal glands, which are essential for maintaining eye moisture and comfort. Recognizing this condition involves understanding its causes, symptoms, diagnosis, and management options.
Causes & Symptoms
Clinical Causes: Autoimmune disorders such as Sjögren's syndrome can lead to gradual destruction of lacrimal glands. Genetic predispositions may contribute to developmental abnormalities affecting tear production. Chronic inflammatory conditions, including chronic blepharitis or conjunctivitis, can damage lacrimal tissue over time. Aging processes naturally reduce gland size and function in some individuals. Certain infections or previous surgeries may result in gland atrophy due to tissue damage.
Key Symptoms: Persistent dry eyes, often feeling gritty or sandy. A sensation of burning or irritation in the eyes. Redness and sensitivity to light. Blurry vision caused by insufficient tear lubrication. Increased tearing as a reflex response to dry eye sensation. Possible formation of corneal ulcers or abrasions in severe cases.
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a comprehensive eye examination that assesses tear production and evaluates lacrimal gland health. Tests may include Schirmer's test, which measures tear production, and imaging studies like MRI or ultrasound to assess gland size and structure. An ophthalmologist will also review medical history and symptoms to distinguish this condition from other causes of dry eye.
Treatment Protocols: Management aims to relieve dry eye symptoms and improve eye comfort. Typical approaches include: - Artificial tears and lubricating eye drops to supplement natural tears. - Anti-inflammatory eye medications in cases where inflammation is present. - Punctal plugs to block tear drainage and conserve moisture. - Lifestyle modifications such as humidifying indoor environments and avoiding irritants. - In some cases, specialized therapies like tear substitutes or cauterization of tear drainage pathways may be recommended. It is important for patients to work with their eye care provider to develop a personalized management plan suited to the severity of their condition.
Clinical Advice & FAQs
Billing Guidance
Is H04.143 a billable ICD-10 code?
Yes, H04.143 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H04.143?
Clinical documentation must specify the nature of Primary lacrimal gland atrophy, bilateral lacrimal glands and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
